Overview
Based in Antwerp, Minze Health develops clinically validated Prescription Digital Therapeutics (PDTs) for urological conditions including bladder dysfunction and incontinence, affecting hundreds of millions of patients globally. The company's solutions are used by over 160,000 patients across 20+ countries, trusted by clinicians as a complement or alternative to pharmacological treatments for lower urinary tract symptoms (LUTS).
Minze raised EUR 3.9M in December 2022 from White Fund, Capricorn Partners, and PMV. In October 2024, the company secured an additional USD 5.3M from the same core syndicate, joined by imec.istart Future Fund as a new investor, bringing total funding to approximately USD 9.2M. In September 2025, Minze entered a strategic collaboration with Apogepha (Germany) to develop a digital therapeutic specifically for male LUTS.
The urology-focused digital therapeutics category is commercially promising given aging demographics across Western Europe and the US, and growing payer and provider interest in validated behavioral and software-based interventions.
Funding history
- December 2022: EUR 3.9M from White Fund, Capricorn Partners, PMV
- October 2024: USD 5.3M from White Fund, Capricorn Digital Growth Fund, PMV, imec.istart Future Fund
Key people
In the news
- 500 HOMEFLOW ORDERS IN THE USA. A significant milestone for Minze Health — and one that deserves a moment. 500 orders means 500 opportunities to give physicians better data, better insight, and a clearer picture of their patients' health outside the clinic. It reflects the hard work of a dedicated team, physicians willing to try a different approach, and the customers and partners who believed in us along the way. To everyone who played a role in getting here — thank you. You believed in the vision, pushed through the
- Minze Health is hiring a regional sales manager for the eastern United States. Come join us to drive commercial growth and adoption of Minze Homeflow alongside Tom Moore DREW STEEH and Daniel Saltino #MedicalDeviceSales #Urology #DigitalHealth
- 𝗪𝗘 𝗔𝗥𝗘 𝗚𝗥𝗢𝗪𝗜𝗡𝗚! 🇺🇸Minze Health is redefining how male LUTS/BPH and overactive bladder (OAB) are diagnosed and managed through innovative home-based digital diagnostics and therapeutics that transform everyday patient data into actionable clinical insights. As we continue our rapid expansion across the United States, we are seeking a high-performing East Regional Manager who will work alongside Tom Moore, DREW STEEH, and Daniel Saltino to drive commercial growth and adoption of the Minze Homeflow® platform
- Exciting news in urology care! Proud to celebrate Dr. Marc Guttman, who is now offering Minze Homeflow to his patients at Precision Healthcare Specialists in Southwest Florida. With deep experience in BPH and minimally invasive treatments, including UroLift, TURP, and Aquablation, Dr. Guttman has built a career around combining clinical expertise with innovative patient care. Homeflow fits naturally with that approach by giving patients a convenient way to complete uroflow testing from home while providing high quality,
- Two major milestones. One incredible team. Last week, we closed the month with two huge achievements at Minze Health: ✅ 100+ HomeFlow orders in a single month, our strongest month yet ✅ 400+ HomeFlow orders year-to-date, a clear sign of the growing demand for better diagnostics in urology These milestones represent far more than numbers. They reflect the trust our physician partners place in us, the dedication of our team, and our shared mission to transform how patients are evaluated for lower urinary tract symptoms. We’re
- Great to see lutastic+ becoming accessible to men with LUTS through HanseMerkur in cooperation with APOGEPHA Arzneimittel GmbH. We look forward to welcoming the first patients through this pathway and are excited to support them with our evidence-based digital therapy in their daily lives. Want to know more, read about our Pilot study: https://lnkd.in/e5qxEXmF
- Exciting news in urology care! 🎉 Proud to celebrate Dr. David Wilkinson, who is now offering Minze HomeFlow to his patients at Precision Healthcare Specialists in Southwest Florida. With more than two decades of experience, a special interest in BPH and overactive bladder, and a reputation for an exceptional bedside manner, Dr. Wilkinson is deeply committed to making patients feel heard, comfortable, and confident in their care. HomeFlow fits naturally with that approach by giving patients a convenient and comfortable
- We're proud to welcome Prof. Stefan De Wachter as Chief Medical Officer of Minze Health. Stefan is no stranger to Minze — he's one of our co-founders. As Head of Urology at University Hospital Antwerp, he's one of the most respected clinical voices in the field, and his thinking has shaped Minze from day one. Stepping into the CMO role, he's bringing that clinical leadership to the very center of how we build. Exactly where it belongs. Minze exists to make urological care better, earlier, and more accessible. That means digital
Alumni
Jiri VermeulenFounding CEO & Board Member
Backers
PMV (ParticipatieMaatschappij Vlaanderen)
Flemish government investment arm with a EUR 1.9B portfolio, backing tech and biotech companies with tickets up to EUR 20M.
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.